Changing epidemiology of invasive candidiasis in children during a 10-year period

Journal of Fungi

Volumn 5, Issue 1, 2019, Pages

  Noni, Maria ^a   Stathi, Angeliki ^b   Vaki, Ilia ^a   Velegraki, Aristea ^c   Zachariadou, Levantia ^b   Michos, Athanasios ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Antifungal; Candidiasis; Children; Invasive; Resistance

Indexed keywords

EID: 85064843072     PISSN: None     EISSN: 2309608X     Source Type: Journal    
DOI: 10.3390/jof5010019     Document Type: Article

References (27)

1. Pfaller, M.A.; Diekema, D.J. Epidemiology of invasive candidiasis: A persistent public health problem. Clin. Microbiol. Rev. 2007, 20, 133–163. [CrossRef] [PubMed]
2. Zaoutis, T. Candidemia in children. Curr. Med. Res. Opin. 2010, 26, 1761–1768. [CrossRef] [PubMed]
3. Pappas, P.G.; Kauffman, C.A.; Andes, D.R.; Clancy, C.J.; Marr, K.A.; Ostrosky-Zeichner, L.; Reboli, A.C.; Schuster, M.G.; Vazquez, J.A.; Walsh, T.J.; et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin. Infect. Dis. 2016, 62, e1–e50. [CrossRef] [PubMed]
4. Hope, W.W.; Castagnola, E.; Groll, A.H.; Roilides, E.; Akova, M.; Arendrup, M.C.; Arikan-Akdagli, S.; Bassetti, M.; Bille, J.; Cornely, O.A.; et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: Prevention and management of invasive infections in neonates and children caused by Candida spp. Clin. Microbial. Infect. 2012, 18, 38–52. [CrossRef] [PubMed]
5. Pfaller, M.A.; Diekema, D.J. Rare and emerging opportunistic fungal pathogens: Concern for resistance beyond Candida albicans and Aspergillus fumigatus. J. Clin. Microbial. 2004, 42, 4419–4431. [CrossRef] [PubMed]
6. Guinea, J. Global trends in the distribution of Candida species causing candidemia. Clin. Microbial. Infect. 2014, 20, 5–10. [CrossRef] [PubMed]
7. Benedict, K.; Roy, M.; Kabbani, S.; Anderson, E.J.; Farley, M.M.; Harb, S.; Harrison, L.H.; Bonner, L.; Wadu, V.L.; Marceaux, K.; et al. Neonatal and Pediatric Candidemia: Results from Population-Based Active Laboratory Surveillance in Four US Locations, 2009–2015. J. Pediatric Infec. Dis. Soc. 2018, 7, e78–e85. [CrossRef]
8. Pfaller, M.A.; Moet, G.J.; Messer, S.A.; Jones, R.N.; Castanheira, M. Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: Report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009). J. Clin. Microbial. 2011, 49, 396–399. [CrossRef]
9. De Pauw, B.; Walsh, T.J.; Donnelly, J.P.; Stevens, D.A.; Edwards, J.E.; Calandra, T.; Pappas, P.G.; Maertens, J.; Lortholary, O.; Kauffman, C.A.; et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 2008, 46, 1813–1821. [CrossRef]
10. Clinical and Laboratory Standards Institute (CLSI). M27–S4: Reference method for broth dilution antifungal susceptibility testing of yeasts, fourth information supplement; Clinical and Laboratory Standards Institute (CLSI): Wayne, PA, USA, 2012.
11. Pfaller, M.A.; Diekema, D.J. Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012. J. Clin. Microbiol. 2012, 50, 2846–2856. [CrossRef]
12. Mesini, A.; Bandettini, R.; Caviglia, I.; Fioredda, F. Candida infections in paediatrics: Results from a prospective single-centre study in a tertiary care children’s hospital. Mycoses 2017, 60, 118–123. [CrossRef] [PubMed]
13. Ota, K.V.; McGowan, K.L. Declining incidence of candidemia in a tertiary inpatient pediatric population. J. Clin. Microbiol. 2012, 50, 1048–1050. [CrossRef] [PubMed]
14. Fisher, B.T.; Ross, R.K.; Localio, A.R.; Prasad, P.A.; Zaoutis, T.E. Decreasing rates of invasive candidiasis in pediatric hospitals across the United States. Clin. Infect. Dis. 2014, 58, 74–77. [CrossRef] [PubMed]
15. Tragiannidis, A.; Fegeler, W.; Rellensmann, G.; Debus, V.; Muller, V.; Hoernig-Franz, I.; Siam, K.; Pana, Z.D.; Jurgens, H.; Groll, A.H. Candidaemia in a European Paediatric University Hospital: A 10-year observational study. Clin. Microbial. Infect. 2012, 18, E27–E30. [CrossRef] [PubMed]
16. Mantadakis, E.; Pana, Z.D.; Zaoutis, T. Candidemia in children: Epidemiology, prevention and management. Mycoses 2018. [CrossRef] [PubMed]
17. Sutcu, M.; Acar, M.; Genc, G.E.; Kokcu, I.; Akturk, H.; Atay, G.; Torun, S.H.; Salman, N.; Erturan, Z.; Somer, A. Evaluation of Candida species and antifungal susceptibilities among children with invasive candidiasis. Turk. Pediatri. Arsivi. 2017, 52, 145–153. [CrossRef] [PubMed]
18. Vogiatzi, L.; Ilia, S.; Sideri, G.; Vagelakoudi, E.; Vassilopoulou, M.; Sdougka, M.; Briassoulis, G.; Papadatos, I.; Kalabalikis, P.; Sianidou, L.; et al. Invasive candidiasis in pediatric intensive care in Greece: A nationwide study. Intens. Care Med. 2013, 39, 2188–2195. [CrossRef] [PubMed]
19. Caudle, K.E.; Inger, A.G.; Butler, D.R.; Rogers, P.D. Echinocandin use in the neonatal intensive care unit. Ann. Pharmacother. 2012, 46, 108–116. [CrossRef] [PubMed]
20. Pfaller, M.A.; Diekema, D.J.; Jones, R.N.; Messer, S.A.; Hollis, R.J. Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000. J. Clin. Microbial. 2002, 40, 852–856. [CrossRef]
21. Alexander, B.D.; Johnson, M.D.; Pfeiffer, C.D.; Jimenez-Ortigosa, C.; Catania, J.; Booker, R.; Castanheira, M.; Messer, S.A.; Perlin, D.S.; Pfaller, M.A. Increasing echinocandin resistance in Candida glabrata: Clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin. Infect. Dis. 2013, 56, 1724–1732. [CrossRef] [PubMed]
22. Pfaller, M.A.; Diekema, D.J.; Andes, D.; Arendrup, M.C.; Brown, S.D.; Lockhart, S.R.; Motyl, M.; Perlin, D.S. Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug Resist. Update. 2011, 14, 164–176. [CrossRef] [PubMed]
23. Arendrup, M.C.; Pfaller, M.A. Caspofungin Etest susceptibility testing of Candida species: Risk of misclassification of susceptible isolates of C. glabrata and C. krusei when adopting the revised CLSI caspofungin breakpoints. Antimicrob. Agents Chemother. 2012, 56, 3965–3968. [CrossRef] [PubMed]
24. Gualco, L.; Debbia, E.A.; Bandettini, R.; Pescetto, L.; Cavallero, A.; Ossi, M.C.; Schito, A.M.; Marchese, A. Antifungal resistance in Candida spp. isolated in Italy between 2002 and 2005 from children and adults. Int. J. Antimicrob. Agents 2007, 29, 179–184. [CrossRef] [PubMed]
25. De Francesco, M.A.; Piccinelli, G.; Gelmi, M.; Gargiulo, F.; Ravizzola, G.; Pinsi, G.; Peroni, L.; Bonfanti, C.; Caruso, A. Invasive Candidiasis in Brescia, Italy: Analysis of Species Distribution and Antifungal Susceptibilities During Seven Years. Mycopathologia 2017, 182, 897–905. [CrossRef] [PubMed]
26. Sarvikivi, E.; Lyytikainen, O.; Soll, D.R.; Pujol, C.; Pfaller, M.A.; Richardson, M.; Koukila-Kahkola, P.; Luukkainen, P.; Saxen, H. Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit. J. Clin. Microbial. 2005, 43, 2729–2735. [CrossRef] [PubMed]
27. Trouve, C.; Blot, S.; Hayette, M.P.; Jonckheere, S.; Patteet, S.; Rodriguez-Villalobos, H.; Symoens, F.; Van Wijngaerden, E.; Lagrou, K. Epidemiology and reporting of candidaemia in Belgium: A multi-centre study. Eur. J. Clin. Microbial. Infect. Dis. 2017, 36, 649–655. [CrossRef] [PubMed]